Elicio Therapeutics, Inc.

ELTX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 33 employees
119
SEC Filings
$11.44
Close 2026-05-29
33
Employees

Business Summary

EX-24.1 6 eltx-powerofattorney2025.htm EX-24.1 eltx-powerofattorney2025 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ELICIO THERAPEUTICS, INC. By: /s/ ROBERT CONNELLY Date: March 12, 2026 Robert Connelly President and Chief Executive Officer (Principal Executive Officer) By: /s/ PREETAM SHAH, PH.D., M.B.A. Date: March 12, 2...

Latest Stock Quote

ELTX 2026-05-29 $11.44 O:$10.61 H:$11.53 L:$10.41 Vol:0.1M VWAP:$11.0779
origin leaf: e1a10a7df3176a82d6ac25de6ec519926a7582277da437c88fbf7dd39ef40fb2

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001601485-26-000027EDGAR111K words
2025-03-312024-12-310001601485-25-000049EDGAR
2024-03-292023-12-310001601485-24-000023EDGAR
2023-03-172022-12-310001601485-23-000011EDGAR
2022-03-302021-12-310001601485-22-000022EDGAR
2021-03-302020-12-310001601485-21-000007EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001601485-25-000124EDGAR20K words
2025-08-072025-06-300001601485-25-000111EDGAR
2025-05-132025-03-310001601485-25-000074EDGAR
2024-11-132024-09-300001601485-24-000075EDGAR
2024-08-132024-06-300001601485-24-000045EDGAR
2024-05-152024-03-310001601485-24-000033EDGAR
2023-11-132023-09-300001601485-23-000082EDGAR
2023-08-142023-06-300001601485-23-000052EDGAR
2023-05-102023-03-310001601485-23-000035EDGAR
2022-11-142022-09-300001601485-22-000070EDGAR
2022-08-152022-06-300001601485-22-000066EDGAR
2022-05-162022-03-310001601485-22-000037EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-160001601485-26-000032EDGAR24K words
2026-03-120001601485-26-000026EDGAR
2025-11-130001601485-25-000123EDGAR
2025-09-170001193125-25-205522EDGAR
2025-08-120001601485-25-000114EDGAR
2025-08-070001601485-25-000108EDGAR
2025-08-050001601485-25-000099EDGAR
2025-06-040001601485-25-000096EDGAR
2025-05-200001601485-25-000076EDGAR
2025-05-130001601485-25-000072EDGAR

119 total filings indexed. 91 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001601485
TickerELTX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.elicio.com
Listed2023-06-02

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 242a7a762a7f755c1ec1a2eda775fa4874b7302c49c67249e4e04bb02514715c
parent: 8c3452ef16427b59b41918103c9501632f9555824dc081a20041b5b107276639
content hash: dd763c77cb97fe45294a5358e79d2e3c52834c1a76770f118a1d4a42f09cd4b8
signed: 2026-06-02T19:00:59.037Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf